ECYT - Endocyte, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue70707070,353.483
Cost of Revenue23,619.74527,492.18526,309.47537,549.389
Gross Profit-23,549.745-27,422.185-26,239.47532,804.094
Operating Expenses
Research Development----
Selling General and Administrative12,740.45313,698.13915,733.46222,377.366
Non Recurring----
Others----
Total Operating Expenses36,360.19841,190.32442,042.93759,926.755
Operating Income or Loss-36,290.198-41,120.324-41,972.93710,426.728
Income from Continuing Operations
Total Other Income/Expenses Net-18,773.952-2,767.249703.188-4,967.251
Earnings Before Interest and Taxes-36,290.198-41,120.324-41,972.93710,426.728
Interest Expense----
Income Before Tax-55,064.15-43,887.573-41,269.7495,459.477
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-55,064.15-43,887.573-41,269.7495,459.477
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-55,064.15-43,887.573-41,269.7495,459.477
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-55,064.15-43,887.573-41,269.7495,459.477